Clinical Trial Update: Early Versus Late Lactoferrin in Prevention of Neonatal Sepsis [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update on early versus late lactoferrin for prevention of neonatal sepsis, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• Lactoferrin (lactoferrin)

Snippet

Sponsor: Ain Shams University | Conditions: Neonatal Sepsis | Phase 4 | Status: COMPLETED